Standardized SEC financial data for Athenex, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001300699 · Pharmaceutical Preparations.
Ratios for fiscal year 2022, standardized from SEC filings.
| USD | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|
| Revenue | $38.0M | $89.1M | $101.2M | $144.4M | $95.4M | $102.8M |
| Cost of revenue | $25.1M | $47.0M | $69.6M | $95.4M | $62.9M | $76.1M |
| Gross profit | $12.9M | $42.1M | $31.6M | $49.0M |
| USD | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $39.3M | $49.8M | $127.7M | $69.6M | $35.2M | $30.4M |
| Inventory | $16.6M | $28.8M | $32.6M | $28.8M | $23.1M | $42.7M |
| Total current assets | $83.8M | $170.8M | $230.9M | $292.0M |
| USD | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$81.5M | -$109.4M | -$97.5M | -$131.2M | -$129.8M | -$64.3M |
| Capital expenditures | $5.4M | $3.3M | $9.7M | $8.6M | $474K | $417K |
| Free cash flow | -$87.0M | -$112.7M | -$107.2M | -$139.9M |
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001300699/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001300699/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"| $32.5M |
| $26.7M |
| R&D expense | $76.8M | $119.9M | $84.4M | $75.9M | $77.7M | $51.8M |
| SG&A expense | $46.1M | $49.0M | $66.3M | $92.9M | $64.2M | $44.9M |
| Operating income | -$110.0M | -$126.8M | -$119.0M | -$119.7M | -$150.4M | -$70.0M |
| EBITDA | -$106.3M | -$123.5M | -$115.2M | -$115.2M | -$145.4M | -$65.5M |
| Interest expense | $6.3M | $3.6M | $7.0M | $11.2M | $20.7M | $25.8M |
| Pretax income | -$131.3M | -$128.6M | -$124.1M | -$140.3M | -$171.0M | -$98.6M |
| Income tax | $85K | $100K | $928K | $4.1M | $10.6M | $347K |
| Net income | -$131.2M | -$117.4M | -$123.7M | -$146.2M | -$199.8M | -$103.4M |
| EPS (diluted) | — | — | — | — | $-38.44 | $-15.81 |
Standardized from Athenex, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.
| $133.4M |
| $124.9M |
| Property, plant & equipment | $9.7M | $11.4M | $23.2M | $23.8M | $3.2M | $1.8M |
| Goodwill | $37.8M | $37.5M | $38.5M | $38.9M | $0 | $0 |
| Total assets | $140.4M | $231.1M | $309.9M | $384.3M | $267.4M | $204.1M |
| Total current liabilities | $45.1M | $51.7M | $71.5M | $62.1M | $96.0M | $114.9M |
| Long-term debt | — | $45.4M | — | — | — | — |
| Total debt | $1.0M | $46.3M | $880K | $1.9M | $46.1M | $37.1M |
| Total liabilities | $49.7M | $102.3M | $134.1M | $219.0M | $233.0M | $228.2M |
| Retained earnings | -$326.3M | -$443.7M | -$567.5M | -$713.6M | -$913.4M | -$1.02B |
| Total equity | $90.7M | $139.4M | $188.2M | $179.8M | $51.1M | -$24.2M |
| -$130.3M |
| -$64.8M |
| Investing cash flow | -$10.0M | -$49.0M | $11.4M | -$119.0M | $127.9M | $7.5M |
| Financing cash flow | $96.9M | $169.0M | $167.5M | $209.5M | $2.7M | $2.4M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 | $0 |